Results 1 to 10 of about 166,232 (161)

Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1. [PDF]

open access: yes, 2016
TGF-β-induced endothelial-to-mesenchymal transition (EndoMT) is a newly recognized source of profibrotic activated myofibroblasts and has been suggested to play a role in the pathogenesis of various fibrotic processes.
Jimenez, Sergio A.   +3 more
core   +15 more sources

GLI2 regulates TGF-β1 in human CD4+ T cells: implications in cancer and HIV pathogenesis. [PDF]

open access: yesPLoS ONE, 2012
Elevated levels of the immunoregulatory cytokine TGF-β1 in cancer and HIV infection have been linked to the suppression of protective immune responses. The transcriptional regulation of TGF-β1 is complex and still not completely understood.
Robert L Furler   +1 more
doaj   +1 more source

Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1. [PDF]

open access: yesPLoS ONE, 2013
Transforming growth factor β1 (TGF-β1) is the pivotal pro-fibrogenic cytokine in hepatic fibrosis. Reducing the over-produced expression of TGF-β1 or blocking its signaling pathways is considered to be a promising therapeutic strategy for hepatic ...
Xiaobao Fan   +6 more
doaj   +1 more source

Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease

open access: yesFrontiers in Immunology, 2022
Chronic liver disease (CLD) is an extremely common clinical condition accompanied by sustained inflammatory response leading to tissue damage. Transforming growth factor-β1 (TGF-β1) is known as a master immune regulator in CLDs, but the association ...
Xuanyan Cai   +19 more
doaj   +1 more source

Canine Transforming Growth Factor-β Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-β1 Immunosuppression

open access: yesFrontiers in Veterinary Science, 2021
Cancer cells can evade host immune systems via multiple mechanisms. Transforming growth factor beta 1 (TGF-β1) is an immunosuppressive cytokine that induces regulatory T cell (Tregs) differentiation and is involved in immune evasion mechanisms in cancer.
Hiroto Takeuchi   +16 more
doaj   +1 more source

TGF-β1 exerts opposing effects on grass carp leukocytes: implication in teleost immunity, receptor signaling and potential self-regulatory mechanisms. [PDF]

open access: yesPLoS ONE, 2012
In fish immunity, the regulatory role of transforming growth factor-β1 (TGF-β1) has not been fully characterized. Here we examined the immunoregulatory effects of TGF-β1 in grass carp peripheral blood leukocytes (PBL) and head kidney leukocytes (HKL). It
Mu Yang   +5 more
doaj   +1 more source

Conditional expression of TGF-β1 in skeletal muscles causes endomysial fibrosis and myofibers atrophy. [PDF]

open access: yesPLoS ONE, 2013
To study the effects of transforming growth factor beta 1 (TGF-β1) on fibrosis and failure of regeneration of skeletal muscles, we generated a tet-repressible muscle-specific TGF-β1 transgenic mouse in which expression of TGF-β1 is controlled by oral ...
Jigna Narola   +3 more
doaj   +1 more source

The relationship between TGF-β1 and cognitive function in the brain

open access: yesBrain Research Bulletin, 2023
Transforming growth factor-β1 (TGF-β1), a multifunctional cytokine, plays a pivotal role in synaptic formation, plasticity, and neurovascular unit regulation.
Chen Su, Jie Miao, Junhong Guo
doaj   +1 more source

Akt activation is required for TGF-β1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: We have previously reported that repeated treatment of human periodontal ligament cells and murine pre-osteoblast MC3T3-E1 cells with transforming growth factor-beta 1 (TGF-β1) inhibited their osteoblastic differentiation because of decreased
Eiichi Suzuki   +6 more
doaj   +1 more source

TGF-β1-overexpressing mesenchymal stem cells reciprocally regulate Th17/Treg cells by regulating the expression of IFN-γ

open access: yesOpen Life Sciences, 2021
Transforming growth factor (TGF)-β1 and mesenchymal stromal cells (MSCs) are two effective immunosuppressive agents for organ transplantation technology.
Li Ruixue   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy